Biden’s SOTU Will Likely Not Focus on Drug Pricing
Although he will touch on the topic, it is unlikely that drug pricing reform will be central to President Biden’s [...]
Medicare Patients Anticipate Troubles Affording Healthcare in 2022
A new survey from MedicalCares.com shows that 60% of Medicare recipients predict they’ll have trouble paying for their healthcare in [...]
Webinar: Why Healthcare Isn’t Working – Another Bandaid vs. Fixing the Core
In a webinar taking place next Wednesday, March 2nd, Bill Nordmark of Enlace Health will argue for a new approach [...]
How Medicare Part B Controls Healthcare Spending
Medicare Part B covers healthcare services ranging from routine checkups to physician-administered medication for complex disorders. However, some take issue [...]
Evidence Doesn’t Suggest Cost-Shifting Between Public and Private Prescription Drug Markets
Recent pushes for drug pricing reforms have reignited worries that such a move would drive prescription prices up in the [...]
Study Finds that Rheumatologists’ Prescribing Habits Influenced by Pharma Payments for Food and Drink
A new study in Mayo Clinic Proceedings found that payments for food and drinks from drug companies were associated with [...]
Over 700 Hospitals Facing Penalties from HAC Reduction Program
764 hospitals across the US will face penalties in 2022 due to not meeting value-based standards set by Medicare’s Hospital-Acquired [...]
Aduhelm Sparks Discourse about Equity in Alzheimer’s Care
The debate over systemic inequity in Alzheimer’s treatment has been stirred once again by Medicare’s proposal to only cover Aduhelm, [...]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s [...]
Biogen’s Alzheimer’s Drug Aduhelm Price Cut in Half
After months of controversy and underwhelming opening sales, Biogen has cut the price of it’s Alzheimer’s drug Aduhelm in half [...]
Major Telehealth Companies Team Up In Preparation of Tightening Regulations
Companies providing telehealth services and platforms are teaming up with lobbyists to push back against the retightening of regulations loosened [...]
Oncology Care Model Reduces Medicare Costs for Cancer Treatment
A study evaluating the benefits of the Oncology Care Model, an alternate payment model for Medicare beneficiaries with cancer, found [...]
Avoiding Medical Bankruptcy with Quizzify Prevent Consent Clause
Half of all Americans have outstanding medical debt, and the same number cannot afford a medical emergency. Bills for emergency [...]
Medicare Price Negotiation Idea Gaining Ground
Allowing Medicare to negotiate drug prices with pharma may soon become policy. A growing number of legislators have publicly expressed [...]
[Book] Available Now: Definitive Guide to Obamacare and the Future Outlook on Universal Healthcare Coverage
A recently published book details the intricacies of the American Care Act and its consequences. Authored by experienced journalist Jonathan [...]
Pfizer Heart Failure Medication Lawsuit Ruling Could Broadly Impact Medicare, Lead to Expensive Aduhelm Coverage
Pfizer is seeking legal backing for its plan to pay healthcare costs for Medicare patients taking one of its pricy [...]
JAMA Article Finds Medicare Overspent on Generics by $2.6 Billion, Costco Delivered Better Value
A recent article published in JAMA Internal Medicine compares Medicare drug spending on generics to Costco. The researchers found that [...]
CEVR and FDA Experts Discuss Medicare’s Options Regarding Aduhelm Coverage
The Food and Drug Administration recently approved Biogen’s new therapy for use in Alzheimer’s disease, Aduhelm. However, Medicare’s decision to [...]
PhRMA Overview of Medicare Programs and Coverage
Medicare covers many aspects of medical care. However, it can be confusing to distinguish among Parts A, B, C, and [...]
Specialty Generics Face Perverse Incentives In Medicare Part D
Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of [...]
Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
Unlike private health insurance, Medicare Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit [...]
CMS Announces Drug Payment Reductions with the “Most Favored Nation” Effective January 1, 2021
Centers for Medicare and Medicaid Services (CMS) announced the long-awaited seven year Most Favored Nation (MFN) model as an interim [...]
Trump Announces Two Rules Aimed at Lowering Drug Prices
President Trump on Friday announced two major actions aimed at reducing the cost of prescription drugs. One action, the ‘Favored [...]
CMS expects MA, Part D payments to grow by nearly 3% in 2022
According to an advanced rate notice, the Trump administration expects Medicare Advantage (MA) and Part D payments to rise by [...]
COVID-19 Vaccine Will Come At No Cost to Medicare Beneficiaries
Once approved, the Trump administration will cover COVID-19 vaccinations at no cost to Medicare beneficiaries. On Wednesday, CMS released an [...]